Mindfulness App for Caregiver Stress

HY
Overseen ByHelen Yates
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hematopoietic stem cell transplant (HCT) patients. Thirty caregivers will use the app for six weeks beginning the week prior to the patient's transplant. Participants will complete baseline and end-of-treatment surveys and a brief qualitative interview.

Who Is on the Research Team?

CV

Christine Vinci, PhD

Principal Investigator

Moffitt Cancer Center

Are You a Good Fit for This Trial?

This trial is for adults over 18 who are caring for someone scheduled to receive a hematopoietic stem cell transplant at Moffitt Cancer Center. Participants must be able to give informed consent, read and write in English, own a smartphone, and be willing to download and use the study app.

Inclusion Criteria

I am the caregiver for a patient scheduled for a transplant at Moffitt Cancer Center.
I can understand and agree to the study's procedures and risks.
I can read and write in English.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Caregivers use the mindfulness-based smartphone application for six weeks, starting the week prior to the patient's transplant

6 weeks
Baseline and end-of-treatment surveys

Follow-up

Participants are monitored for engagement and usability of the app after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Mindfulness-Based Smartphone Application

Trial Overview

The study is testing a mindfulness-based smartphone application designed for caregivers of HCT patients. Thirty caregivers will use the app starting one week before the patient's transplant and continue for six weeks, with surveys and an interview conducted to assess its impact.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: AppExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

H. Lee Moffitt Cancer Center and Research Institute

Lead Sponsor

Trials
576
Recruited
145,000+

American Cancer Society, Inc.

Collaborator

Trials
237
Recruited
110,000+